Stabilin receptors clear LPS and control systemic inflammation
Summary: Lipopolysaccharides (LPSs) cause lethal endotoxemia if not rapidly cleared from blood circulation. Liver sinusoidal endothelial cells (LSEC) systemically clear LPS by unknown mechanisms. We discovered that LPS clearance through LSEC involves endocytosis and lysosomal inactivation via Stabil...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/209b703b99394a00aadccb8cd283ebee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:209b703b99394a00aadccb8cd283ebee |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:209b703b99394a00aadccb8cd283ebee2021-11-20T05:10:07ZStabilin receptors clear LPS and control systemic inflammation2589-004210.1016/j.isci.2021.103337https://doaj.org/article/209b703b99394a00aadccb8cd283ebee2021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2589004221013067https://doaj.org/toc/2589-0042Summary: Lipopolysaccharides (LPSs) cause lethal endotoxemia if not rapidly cleared from blood circulation. Liver sinusoidal endothelial cells (LSEC) systemically clear LPS by unknown mechanisms. We discovered that LPS clearance through LSEC involves endocytosis and lysosomal inactivation via Stabilin-1 and 2 (Stab1 and Stab2) but does not involve TLR4. Cytokine production was inversely related to clearance/endocytosis of LPS by LSEC. When exposed to LPS, Stabilin double knockout mice (Stab DK) and Stab1 KO, but not Stab2 KO, showed significantly enhanced systemic inflammatory cytokine production and early death compared with WT mice. Stab1 KO is not significantly different from Stab DK in circulatory LPS clearance, LPS uptake and endocytosis by LSEC, and cytokine production. These data indicate that (1) Stab1 receptor primarily facilitates the proactive clearance of LPS and limits TLR4-mediated inflammation and (2) TLR4 and Stab1 are functionally opposing LPS receptors. These findings suggest that endotoxemia can be controlled by optimizing LPS clearance by Stab1.Fatima CabralMustafa Al-RahemJohn SkaggsThushara A. ThomasNaresh KumarQian WuPaolo FaddaLianbo YuJohn M. RobinsonJonghan KimEkta PandeyXinghui SunWael N. JarjourMurugesan V.S. RajaramEdward N. HarrisLatha P. GanesanElsevierarticleBiological sciencesMolecular biologyImmune responseScienceQENiScience, Vol 24, Iss 11, Pp 103337- (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Biological sciences Molecular biology Immune response Science Q |
spellingShingle |
Biological sciences Molecular biology Immune response Science Q Fatima Cabral Mustafa Al-Rahem John Skaggs Thushara A. Thomas Naresh Kumar Qian Wu Paolo Fadda Lianbo Yu John M. Robinson Jonghan Kim Ekta Pandey Xinghui Sun Wael N. Jarjour Murugesan V.S. Rajaram Edward N. Harris Latha P. Ganesan Stabilin receptors clear LPS and control systemic inflammation |
description |
Summary: Lipopolysaccharides (LPSs) cause lethal endotoxemia if not rapidly cleared from blood circulation. Liver sinusoidal endothelial cells (LSEC) systemically clear LPS by unknown mechanisms. We discovered that LPS clearance through LSEC involves endocytosis and lysosomal inactivation via Stabilin-1 and 2 (Stab1 and Stab2) but does not involve TLR4. Cytokine production was inversely related to clearance/endocytosis of LPS by LSEC. When exposed to LPS, Stabilin double knockout mice (Stab DK) and Stab1 KO, but not Stab2 KO, showed significantly enhanced systemic inflammatory cytokine production and early death compared with WT mice. Stab1 KO is not significantly different from Stab DK in circulatory LPS clearance, LPS uptake and endocytosis by LSEC, and cytokine production. These data indicate that (1) Stab1 receptor primarily facilitates the proactive clearance of LPS and limits TLR4-mediated inflammation and (2) TLR4 and Stab1 are functionally opposing LPS receptors. These findings suggest that endotoxemia can be controlled by optimizing LPS clearance by Stab1. |
format |
article |
author |
Fatima Cabral Mustafa Al-Rahem John Skaggs Thushara A. Thomas Naresh Kumar Qian Wu Paolo Fadda Lianbo Yu John M. Robinson Jonghan Kim Ekta Pandey Xinghui Sun Wael N. Jarjour Murugesan V.S. Rajaram Edward N. Harris Latha P. Ganesan |
author_facet |
Fatima Cabral Mustafa Al-Rahem John Skaggs Thushara A. Thomas Naresh Kumar Qian Wu Paolo Fadda Lianbo Yu John M. Robinson Jonghan Kim Ekta Pandey Xinghui Sun Wael N. Jarjour Murugesan V.S. Rajaram Edward N. Harris Latha P. Ganesan |
author_sort |
Fatima Cabral |
title |
Stabilin receptors clear LPS and control systemic inflammation |
title_short |
Stabilin receptors clear LPS and control systemic inflammation |
title_full |
Stabilin receptors clear LPS and control systemic inflammation |
title_fullStr |
Stabilin receptors clear LPS and control systemic inflammation |
title_full_unstemmed |
Stabilin receptors clear LPS and control systemic inflammation |
title_sort |
stabilin receptors clear lps and control systemic inflammation |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/209b703b99394a00aadccb8cd283ebee |
work_keys_str_mv |
AT fatimacabral stabilinreceptorsclearlpsandcontrolsystemicinflammation AT mustafaalrahem stabilinreceptorsclearlpsandcontrolsystemicinflammation AT johnskaggs stabilinreceptorsclearlpsandcontrolsystemicinflammation AT thusharaathomas stabilinreceptorsclearlpsandcontrolsystemicinflammation AT nareshkumar stabilinreceptorsclearlpsandcontrolsystemicinflammation AT qianwu stabilinreceptorsclearlpsandcontrolsystemicinflammation AT paolofadda stabilinreceptorsclearlpsandcontrolsystemicinflammation AT lianboyu stabilinreceptorsclearlpsandcontrolsystemicinflammation AT johnmrobinson stabilinreceptorsclearlpsandcontrolsystemicinflammation AT jonghankim stabilinreceptorsclearlpsandcontrolsystemicinflammation AT ektapandey stabilinreceptorsclearlpsandcontrolsystemicinflammation AT xinghuisun stabilinreceptorsclearlpsandcontrolsystemicinflammation AT waelnjarjour stabilinreceptorsclearlpsandcontrolsystemicinflammation AT murugesanvsrajaram stabilinreceptorsclearlpsandcontrolsystemicinflammation AT edwardnharris stabilinreceptorsclearlpsandcontrolsystemicinflammation AT lathapganesan stabilinreceptorsclearlpsandcontrolsystemicinflammation |
_version_ |
1718419529784098816 |